miR-204 overexpression in GC cell lines CTC105 and CTC141 reduces transient receptor potential melastatin 3 (TRPM3), an activator of oncogenic autophagy-miR-204, which can be used as a target in GC therapy. Here, TRPM3 is linked to gastric cancer.